Skip to content

Clinical trials

Phase 1 Antiphospholipid Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Antiphospholipid Syndrome Phase: Phase 1 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20244
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Not yet recruiting2
Active, not recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China Immunotech (Beijing) Biotechnology Co., Ltd.5
Chugai Pharmaceutical2
Children's Hospital of Fudan University1
First Affiliated Hospital of Wenzhou Medical University1
Peking University Third Hospital1
Polina Stepensky1
Richard Burt, MD1
Shanghai Lanyi Therapeutics Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Antiphospholipid Syndrome13
Lupus Erythematosus, Systemic9
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis8
Myositis8
Scleroderma, Systemic6
Sjogren's Syndrome5
Autoimmune Diseases3
Lupus Nephritis3
Arthritis, Rheumatoid2
Behcet Syndrome2

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.